0001415889-20-001938.txt : 20200720
0001415889-20-001938.hdr.sgml : 20200720
20200720215342
ACCESSION NUMBER: 0001415889-20-001938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190613
FILED AS OF DATE: 20200720
DATE AS OF CHANGE: 20200720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pennington James
CENTRAL INDEX KEY: 0001668704
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37853
FILM NUMBER: 201037488
MAIL ADDRESS:
STREET 1: 25801 INDUSTRIAL BLVD
STREET 2: SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AzurRx BioPharma, Inc.
CENTRAL INDEX KEY: 0001604191
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
BUSINESS PHONE: 646-699-7855
MAIL ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharma d'Azur, Inc.
DATE OF NAME CHANGE: 20140331
4
1
form4-07202020_060734.xml
X0306
4
2019-06-13
0001604191
AzurRx BioPharma, Inc.
AZRX
0001668704
Pennington James
C/O AZURRX BIOPHARMA, INC.
760 PARKSIDE AVE SUITE 304
BROOKLYN
NY
11226
false
true
false
false
CHIEF MEDICAL OFFICER
Stock option (right to buy)
1.75
2019-06-13
4
A
0
110000
0
A
2024-06-12
Common stock, par value $0.0001 per share
110000
110000
D
The stock option vests, if at all, upon the achievement of certain specified performance targets. Vesting is conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date.
/s/ James E. Pennington
2020-07-20